Fingerprint
Dive into the research topics of 'The Landmark Series: Neoadjuvant Chemotherapy for Triple-Negative and HER2-Positive Breast Cancer'. Together they form a unique fingerprint.- Sort by
- Weight
- Alphabetically
The Landmark Series: Neoadjuvant Chemotherapy for Triple-Negative and HER2-Positive Breast Cancer
Roberto A. Leon-Ferre, Tina J. Hieken, Judy C. Boughey
Research output: Contribution to journal › Article › peer-review